Long Term Suspended Entities
Filed with ASX · · 6 pages · English
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Suspension from Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
- Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
- Preliminary Final Report
Later from Zelira Therapeutics
All Zelira Therapeutics news releasesFollow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics